• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Jonathan Avery Explains How Substance Use Affects the Care of Patients With Mental Illness

Video

Jonathan Avery, MD, director of addiction psychiatry, New York-Presbyterian Hospital, Weill Cornell Medical Center, discussed how some psychiatrists will back away when treating a patient with co-occurring substance use and mental illness, when instead they should be leaning in to deliver evidence-based treatment.

Jonathan Avery, MD, director of addiction psychiatry, New York-Presbyterian Hospital, Weill Cornell Medical Center, discussed how some psychiatrists will back away when treating a patient with co-occurring substance use and mental illness, when instead they should be leaning in to deliver evidence-based treatment.

Transcript

How do concurrent substance use disorders affect how psychiatrists treat patients with mental illnesses?

Our hope is that co-occurring disorders cause a psychiatrist to lean in and offer all the evidence-based treatments. I think in practice what happens is that we tend to back out of the room when it looks like a complicated patient has multiple diagnoses, especially substance use disorders, and I think we tend to undertreat or refer out and not treat ourselves. And part of that is stigma-related, I think it’s been shown repeatedly that doctors have worse attitudes towards patients with co-occurring disorders than towards more simple cases. We really want them to not do non—evidence-based things, to not sort of back away but really to offer all the evidence-based treatments for the different diagnoses that they have.

Related Videos
Darius Lakdawalla, PhD, director of research, USC Schaeffer Center
Screenshot of Ryan Nix, PharmD, during a video interview
Screenshot of Fran Gregory, PharmD, MBA, during a video interview
dr martin dahl
Screenshot of Christie Smith, PharmD, MBA, during a video interview
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Leslie Fish, PharmD.
Adam Colborn, JD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.